Shenzhen Mindray Bio-Medical Electronics Co. Ltd.

Company Snapshot

Founded: 1991
Entity Type: Public
Employees: 18000
Region: China
Revenue: $4,518.0 Millions
Revenue Year: 2022
Headquarter: China
Key Geographics: North America, Europe, Asia-Pacific, Middle East and Africa
Corporate Address: Mindray Building, Keji 12th Road South High-Tech Industrial Park, Nanshan Shenzhen 518057 People Republic of China (P.R. China) Tel. +86-755-8188-8997 www.mindray.com

Company Overview

Mindray is a prominent international provider of medical devices and solutions. It operates through three business segments: Patient Monitoring & Life Support, In-Vitro Diagnostics, and Medical Imaging.

The company offers infusion pumps and devices through the Patient Monitoring & Life Support segment. This segment includes ventilators, defibrillators, anesthesia machines, operating tables, surgical lights, medical supply units, infusion pumps, electrocardiographs, complete OR/ICU solutions, patient monitoring and life support instruments, surgical endoscopic systems, cold light sources, insufflators, optical endoscopes, ultrasonic dissection devices, energy platforms, surgical instruments, and surgical consumables, along with other minimally invasive surgical products.

The company emerged as a strong market presence in China and other Asian countries. The company also has a significant market presence in different parts of the world and aims to capture developed markets. It offers products and services to healthcare facilities in over 190 countries and regions.

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***

This information is available for BCC Research members only.

Shenzhen Mindray Bio-Medical Electronics Co. Ltd. In Reports

Infusion Pumps and Devices: Technologies and Global Markets

BCC Research Market Analyst says global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a CAGR of 7.7%.

In Vitro Diagnostics (IVD) Analyzers: Global Market

BCC Research Market Report says global market for In Vitro Diagnostics analyzers is estimated to increase from $12.9 billion in 2023 to reach $16.3 billion by 2028, at a (CAGR of 4.7%.

Hematology Analyzer Market

According to BCC Research Report global market for hematology analyzers is estimated to increase from $4.0 billion in 2023 to reach $5.3 billion by 2028 at a CAGR of 5.7%.

Company's Business Segments

  • Products : This segment includes Patient Monitoring, Ultrasound, Radiology, AED, Defibrillation System, Anesthesia, CLIA, Chemistry, Hematology, Ventilators, Electrocardiograph, Endoscope Camera System, Operating Tables, Surgical Lights, Medical Supply Units, Infusion System, Orthopaedics, IT Products, Animal Medical, and Artema GAS Module.
  • Solutions : This segment comprises Hospitalwide Solutions, Emergency Care Solutions, Critical Care Solutions, Medical Imaging, Peri-Operative Care Solutions, Minimally Invasive Surgery, and Laboratory Diagnostics.
  • Services : This segment provides services such as M-Connect, Standardized Laboratory, IoT, and service solutions such as Customer care center, Technical Support Center, Spare Parts Center, Training Center, and CRM Platform.

Applications/End User Industries

  • Healthcare
  • Medical Devices